| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d8d590800a0e0f9adadcfd14bbb630e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ddb5193471ae29da9c0e70c0a51595c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-559
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-555 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate |
1999-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c336dd7b02476af1cea139ca8e0dab2e |
| publicationDate |
1999-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9953908-A2 |
| titleOfInvention |
Pro-drug conjugates for the treatment of stroke and other ischaemic conditions |
| abstract |
A prodrug represented by the Formula (I): A - X - B, wherein A comprises a carrier that selectively effects release of B at hypoxic sites in the brain; X comprises a cleavable linker; and B comprises at least one active moiety of a therapeutic agent for the treatment of stroke or other ischaemic conditions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005113011-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7977373-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005113011-A2 |
| priorityDate |
1998-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |